Pamela Davis
Family Medicine · Pleasant Hill, MONPI 1336144930
Payments from drug & device makers
Across 149 payments — averaging $15.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$527
- Boehringer Ingelheim$321
- Supernus Pharmaceuticals, Inc.$268
- AstraZeneca$252
- Otsuka America Pharmaceutical, Inc.$113
- Antares Pharma, Inc.$90
- plus $729 from 16 others
What the payments were for
- Food & beverage$2,24998%
- Education$512%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 35 | $527 |
| Boehringer Ingelheim | 20 | $321 |
| Supernus Pharmaceuticals, Inc. | 19 | $268 |
| AstraZeneca | 15 | $252 |
| Otsuka America Pharmaceutical, Inc. | 7 | $113 |
| Antares Pharma, Inc. | 6 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $88 |
| GSK | 5 | $86 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $69 |
| Merck | 5 | $64 |
| Johnson & Johnson | 4 | $57 |
| Novo Nordisk | 4 | $57 |
| Pfizer | 4 | $56 |
| Astellas Pharma US Inc | 3 | $53 |
| Amgen(2 entities) | 3 | $51 |
| Shire North American Group Inc | 2 | $38 |
| Lilly USA, LLC | 2 | $29 |
| Upsher-smith Laboratories LLC | 1 | $21 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Ironshore Pharmaceuticals Inc. | 1 | $16 |
| Galderma Laboratories, L.p. | 1 | $15 |
| Genentech USA, Inc. | 1 | $13 |
How this compares
$2,299 in reported general payments places this provider in the 75th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 172 | $146,555 |
| OzempicSemaglutide | 115 | $135,948 |
| EliquisApixaban | 108 | $68,894 |
| MounjaroTirzepatide | 61 | $65,755 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 73 | $61,998 |
| XareltoRivaroxaban | 72 | $58,319 |
| TrulicityDulaglutide | 44 | $48,634 |
| JanuviaSitagliptin Phosphate | 55 | $39,967 |
| TradjentaLinagliptin | 48 | $32,989 |
| CreonLipase/Protease/Amylase | 17 | $31,189 |
| MyrbetriqMirabegron | 40 | $25,677 |
| RexultiBrexpiprazole | 13 | $19,660 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 45 | $18,074 |
| JanumetSitagliptin Phos/Metformin Hcl | 19 | $17,460 |
| LinzessLinaclotide | 26 | $15,940 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat | $321 | $188,498235 claims |
| Novo NordiskOzempic | $57 | $135,948115 claims |
| Lilly USA, LLCMounjaro, Trulicity | $29 | $114,389105 claims |
| GSKTrelegy Ellipta, Shingrix, Breo Ellipta, Anoro Ellipta, Incruse Ellipta | $86 | $97,271174 claims |
| MerckJanuvia, Janumet Xr, Janumet | $64 | $75,502119 claims |
| Johnson & JohnsonXarelto, Invokana | $57 | $70,64987 claims |
| PfizerEliquis | $56 | $68,894108 claims |
| AbbVieCreon, Linzess | $527 | $47,12943 claims |
| AstraZenecaSymbicort, Farxiga, Nexium | $252 | $30,14064 claims |
| Astellas Pharma US IncMyrbetriq | $53 | $25,67740 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $113 | $19,66013 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $88 | $6,07712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Pleasant Hill
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
- George CarrJefferson City$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.